| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MetaVia Inc. | Chief Financial Officer | Common Stock | 30.1K | $19.6K | $0.65 | Aug 12, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MTVA | MetaVia Inc. | Aug 12, 2025 | 1 | $0 | 4 | Aug 13, 2025 | Chief Financial Officer |
| MTVA | MetaVia Inc. | Jun 4, 2025 | 1 | $9.94K | 4 | Jun 4, 2025 | Chief Financial Officer |
| MTVA | MetaVia Inc. | Mar 1, 2025 | 1 | -$4.99K | 4 | Mar 4, 2025 | Chief Financial Officer |
| NRBO | NeuroBo Pharmaceuticals, Inc. | Mar 1, 2024 | 1 | $0 | 4 | Mar 4, 2024 | Chief Financial Officer |
| NRBO | NeuroBo Pharmaceuticals, Inc. | Oct 27, 2023 | 0 | $0 | 3 | Oct 30, 2023 | Acting Chief Financial Officer |